Observe Medical ASA - Disclosure of large shareholding
Mandatory disclosure pursuant to section 4-2 of the Norwegian Securities Trading Act by Navamedic ASA. Reference is made to the previous stock exchange announcements from Observe Medical ASA (the "Company") announcing a fully underwritten rights issue of 25,714,286 new shares in the Company, raising gross proceeds of approximately NOK 180 million (the "Rights Issue"). In the Rights Issue, each existing shareholder of the Company as of 4 February 2022 (and being registered as such in Euronext Securities Oslo, the Norwegian Central Securities Depository (the "VPS") as at the expiry of 8